John M. Kane III, MD, FACS
Dr. John M. Kane is a surgical oncologist at Roswell Park Comprehensive Cancer Center. Though much of his focus is on treating melanoma and sarcoma, his interest in isolated regional therapy led to him developing the cytoreduction/hyperthermic intraperitoneal chemoperfusion program at Roswell Park in 2002. The center is one of the few locations in the state of New York that offers the complex procedure, which has proven to be effective in extending survival and improving the quality of life for patients with malignant peritoneal mesothelioma. Though Dr. Kane no longer performs the HIPEC procedure as part of his regular practice, he continues to play an active role in the center’s program.[1]
Education and Career
Dr. Kane earned his medical degree at the Johns Hopkins School of Medicine in Baltimore, Maryland, then completed an internship and residency in Surgery at the University of Pittsburgh. He followed these experiences with a research fellowship in the University of Pittsburgh’s Department of Surgery and a clinical fellowship in the Department of Surgical Oncology at Roswell Park Cancer Institute.
Dr. Kane has served as the Surgical Oncology Fellowship Program Director and on the Executive Council of the Society of Surgical Oncology. He is a fellow of the American College of Surgeons and of several other surgical and oncologic societies, including:[1]
- Society of Surgical Oncology
- Western New York American College of Surgeons
- NRG Sarcoma Working Group
- Buffalo Surgical Society
- American College of Surgeons (ACS)
- ACS – Clinical Research Program Cancer Care Standards Development Committee–Melanoma and Sarcoma Disease Sites
Research
In addition to his earlier work on peritoneal mesothelioma, Dr. Kane has been the lead investigator for several sarcoma trials and has authored multiple papers on the topic. He has also been an invited speaker at national and international meetings. His notable presentations on the use of the HIPEC procedure include:[1]
Invited International
- Invited Talk: Standardization of HIPEC –Indications. Fifth International Symposium on Regional Cancer Therapies, Carolina, Puerto Rico, February 20 – 22, 2010
- Workshop entitled “Establishing a Regional Therapy Program”. Second International Symposium on Regional Cancer Therapies. San Juan, Puerto Rico; February 25, 2007
- Invited Moderator-Second International Symposium on Regional Cancer Therapies. San Juan, Puerto Rico; February 25, 2007
- Talk entitled “Current Concepts in Surgical Management of Peritoneal Carcinomatosis: Who & What?” at the Canadian Association of General Surgeons. Montreal, Canada; September 9, 2005
Invited National
- Invited speaker: 15th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, topic: The Role of Surgery in the Melanoma Immunotherapy Era, Chapel Hill, NC, April 28-29, 2022
- Invited moderator: HIPEC Outcomes/Survival. Society of Surgical Oncology International Conference on Surgical Cancer Care, Boston, MA, August 17-19, 2020
